Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein A.

about

PRTX-100 and methotrexate in patients with active rheumatoid arthritis: A Phase Ib randomized, double-blind, placebo-controlled, dose-escalation study.Local retention of antibodies in vivo with an injectable film embedded with a fluorogen-activating protein.

P2860

Q39809621-C9D8E0F5-75B1-4E4B-9D97-6DDAF6B844BC Q47109031-10F94790-16BD-4BF6-94E6-0356790C01B0

P2860

Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein A.

Item

http://www.wikidata.org/entity/Q50853279

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Safety, pharmacokinetic, immun ...... fied staphylococcal protein A.

@en

Safety, pharmacokinetic, immun ...... fied staphylococcal protein A.

@nl

type

Item

label

Safety, pharmacokinetic, immun ...... fied staphylococcal protein A.

@en

Safety, pharmacokinetic, immun ...... fied staphylococcal protein A.

@nl

prefLabel

Safety, pharmacokinetic, immun ...... fied staphylococcal protein A.

@en

Safety, pharmacokinetic, immun ...... fied staphylococcal protein A.

@nl

P1476

Safety, pharmacokinetic, immun ...... fied staphylococcal protein A.

@en

P2093

Anissa Leh

http://www.w3.org/2001/XMLSchema#string

Charles Ballow

http://www.w3.org/2001/XMLSchema#string

David Haughey

http://www.w3.org/2001/XMLSchema#string

Edward Bernton

http://www.w3.org/2001/XMLSchema#string

Jim Yan

http://www.w3.org/2001/XMLSchema#string

Kimberly Slentz-Kesler

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity

Mechanisms of type-I- and type-II-interferon-mediated signalling

Pathogenesis of B-cell superantigen-induced immune complex-mediated inflammation.

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program.

Proficiency testing/external quality assurance for the PFA-100(®).

Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxin.

The cutaneous reaction to staphylococcal protein A in normal subjects and patients with atopic dermatitis or psoriasis.

Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients

P304

909-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.119

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23832863

http://www.w3.org/2001/XMLSchema#string

Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein A.

about

P2860

P2860

Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein A.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698